Kumagai H, Suzuki H, Ichikawa M, Matsumura Y, Jimbo M, Ryuzaki M, Saruta T
Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Circ Res. 1993 Jun;72(6):1255-65. doi: 10.1161/01.res.72.6.1255.
This study was designed to elucidate how central and peripheral arginine vasopressin (AVP) interacts with the sympathetic nervous system and the renin-angiotensin system to maintain blood pressure in two-kidney, one-clip hypertensive rabbits. We recorded renal sympathetic nerve activity (RSNA) in the conscious state as an index of sympathetic nervous system function. The changes in mean arterial pressure, heart rate, and RSNA were recorded continuously for 60 minutes after intravenous administrations of captopril (2.5 mg/kg) and nicardipine (3.2 micrograms.kg-1.min-1) in eight identical rabbits. Despite equivalent reductions in mean arterial pressure (10 +/- 1 mm Hg), the increase in RSNA was significantly larger with captopril than that with nicardipine, and the plasma concentration of AVP was elevated (from 100% to 255 +/- 24%) with captopril. Mean arterial pressure was reduced, and RSNA was increased by intravenous infusion of AVP antagonist d(CH2)5Tyr(Me)AVP (n = 8), whereas vertebral artery infusion of the antagonist (n = 6) did not change RSNA. During central and peripheral infusions of AVP antagonist, RSNA was exaggerated by blood pressure reduction with nicardipine as well as with captopril. Increases in RSNA induced by captopril and nicardipine were larger by central infusion of AVP antagonist than by intravenous infusion. The decrease in mean arterial pressure by captopril (30 +/- 4 mm Hg) in eight sinoaortic-denervated hypertensive rabbits was larger than that in hypertensive rabbits with intact baroreflex. These data suggest that compensatory activation of RSNA was revealed by central and peripheral attenuation of AVP and that the sympathetic nervous system became the most important mechanism for blood pressure maintenance in the absence of AVP. The interaction of AVP with the sympathetic nervous system may be independent of the state of the renin-angiotensin system, since the exaggeration of RSNA by AVP antagonist was qualitatively the same with nicardipine as with captopril. In conscious renal-hypertensive rabbits, AVP in the central nervous system played a substantial role when blood pressure was reduced, although it did not contribute to blood pressure maintenance in the basal condition.
本研究旨在阐明中枢和外周精氨酸加压素(AVP)如何与交感神经系统和肾素-血管紧张素系统相互作用,以维持二肾一夹高血压兔的血压。我们记录清醒状态下的肾交感神经活动(RSNA)作为交感神经系统功能的指标。在8只相同的兔子静脉注射卡托普利(2.5mg/kg)和尼卡地平(3.2μg·kg-1·min-1)后,连续60分钟记录平均动脉压、心率和RSNA的变化。尽管平均动脉压同等程度降低(10±1mmHg),但卡托普利引起的RSNA升高显著大于尼卡地平,且卡托普利使AVP血浆浓度升高(从100%升至255±24%)。静脉输注AVP拮抗剂d(CH2)5Tyr(Me)AVP(n=8)可使平均动脉压降低,RSNA升高,而椎动脉输注该拮抗剂(n=6)则不改变RSNA。在中枢和外周输注AVP拮抗剂期间,尼卡地平和卡托普利降低血压均会使RSNA夸大。与静脉输注相比,中枢输注AVP拮抗剂时,卡托普利和尼卡地平引起的RSNA升高幅度更大。8只去窦弓神经高血压兔中,卡托普利使平均动脉压降低(30±4mmHg)的幅度大于压力感受性反射完整的高血压兔。这些数据表明,AVP的中枢和外周减弱可揭示RSNA的代偿性激活,且在缺乏AVP时,交感神经系统成为维持血压的最重要机制。AVP与交感神经系统的相互作用可能独立于肾素-血管紧张素系统的状态,因为AVP拮抗剂对RSNA的夸大作用在尼卡地平和卡托普利作用下在性质上是相同的。在清醒的肾性高血压兔中,中枢神经系统中的AVP在血压降低时起重要作用,尽管在基础状态下它对血压维持无贡献。